Assembly Biosciences, Inc.

BST:V7B Stock Report

Market Cap: €584.6m

Assembly Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

BST:V7B Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Jun 26Sell€582Jeanette BjorkquistIndividual29€20.06
30 Mar 26Sell€4,590Nicole WhiteIndividual197€24.00
30 Mar 26Sell€7,644Jeanette BjorkquistIndividual328€24.00

Insider Trading Volume

Insider Buying: V7B insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of V7B?
Owner TypeNumber of SharesOwnership Percentage
General Public199,8310.981%
Individual Insiders616,0733.03%
VC/PE Firms1,020,4105.01%
Hedge Funds4,573,33822.5%
Public Companies4,977,08924.4%
Institutions8,973,85544.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 30.9%.


Top Shareholders

Top 25 shareholders own 89.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.4%
Gilead Sciences, Inc.
4,977,089€142.9m10.5%no data
7.88%
Farallon Capital Management, L.L.C.
1,604,590€46.1m30.7%0.27%
7.63%
Paradigm Biocapital Advisors LP
1,553,748€44.6m134%0.94%
6.95%
Commodore Capital LP
1,415,000€40.6m41.5%2.31%
6.68%
Janus Henderson Group Ltd.
1,359,514€39.0m60.1%0.01%
5.01%
RA Capital Management, L.P.
1,020,410€29.3m0%0.25%
3.77%
BlackRock, Inc.
766,819€22.0m278%no data
3.54%
Parkman Healthcare Partners LLC
721,181€20.7m75.4%2.11%
3.11%
Vanguard Capital Management, LLC
632,912€18.2m12.6%no data
2.67%
Alexander Schornstein
543,523€15.6m0%no data
2.26%
Point72 Asset Management, L.P.
460,593€13.2m33.9%0.02%
2.13%
Seven Fleet Capital Management LP
433,147€12.4m671%2.07%
1.47%
Millennium Management LLC
298,807€8.6m27.9%0.01%
1.46%
Blackstone Alternative Asset Management L.P.
296,855€8.5m0%0.63%
1.38%
Geode Capital Management, LLC
280,424€8.1m111%no data
1.19%
Schonfeld Strategic Advisors LLC
242,153€7.0m101%0.04%
1.13%
Columbia Management Investment Advisers, LLC
230,000€6.6m0%no data
1.11%
DV Equities, LLC
226,415€6.5m0%0.96%
1.02%
Aberdeen Group Plc
207,047€5.9m0%no data
0.93%
Affinity Asset Advisors, LLC
190,000€5.5m0%0.26%
0.86%
The B Group, Inc.
175,706€5.0m0%2.67%
0.84%
State Street Investment Management
171,931€4.9m203%no data
0.84%
StemPoint Capital LP
170,378€4.9m-8.12%0.88%
0.79%
Squadron Capital Management LLC
160,000€4.6m0%1.66%
0.74%
Woodline Partners LP
150,780€4.3m0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/21 17:39
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Assembly Biosciences, Inc. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Madhu KumarB. Riley Securities, Inc.
Irina Rivkind KofflerCantor Fitzgerald & Co.